Aurora Cannabis Inc
ACB Nasdaq· Medicinal Chemicals & Botanical Products
Last close · Oct 27, 2026
$4.15
KIRA · Stoqly’s AI analyst, in plain words
- Aurora Cannabis Inc had $232M of revenue in fiscal 2026, up 11.7% on the year before. Over five years, revenue changed +3.9% a year on average.
- Aurora Cannabis Inc lost $98.4M in fiscal 2026.
- Aurora Cannabis Inc has $46.4M more cash than debt.
Market cap
$238M
P/E
—
Revenue
$232M
Net income
−$98.4M
Free cash flow
—
Operating margin
—
Aurora Cannabis Inc in 30 seconds · fiscal 2026
Are sales growing?
+11.7%
Yes. Sales grew 11.7% last year.
Does it make a profit?
−42.4%
No. It lost money last year.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Aurora Cannabis Inc does
No business description yet.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 40-F · Jun 11, 2026
- Legal name
- AURORA CANNABIS INC
- CIK
- 0001683541
Aurora Cannabis Inc · ACB
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $191M | $175M | — | $208M | $232M |
| Revenue growth | −4.5% | −8.5% | — | — | 11.7% |
| Gross margin | −8.8% | 9.6% | — | 62.6% | 42.6% |
| Operating margin | −115.3% | −104.6% | — | 1.7% | — |
| Net income | −$539M | −$1.4B | — | $1.1M | −$98.4M |
| Net margin | −282.2% | −776.0% | — | 0.6% | −42.4% |
| Diluted EPS | −$3.20 | −$6.31 | — | $0.03 | −$1.55 |
| Cash | |||||
| Cash from operations | −$164M | −$87.1M | — | $11.5M | −$9.8M |
| Capital expenditure | $41.4M | $25.5M | — | — | — |
| Free cash flow | −$206M | −$113M | — | — | — |
| FCF margin | −107.5% | −64.4% | — | — | — |
| Share count change | 74.8% | 27.1% | — | — | 3.0% |
| Debt and strength | |||||
| Cash and short-term investments | $340M | $339M | $100M | $96.0M | $46.4M |
| Debt incl. finance leases | — | $0.0M | $42.2M | $43.0M | $0.0M |
| Shareholders' equity | $1.6B | $512M | $412M | $395M | $367M |
| Net debt / EBITDA | — | — | — | −9.3x | — |
| Current ratio | 5.7x | 5.7x | 3.4x | 4.3x | 5.9x |
| Interest coverage | −4.3x | −3.2x | — | 2.0x | — |
| Returns and quality | |||||
| Return on capital | — | −83.4% | — | 0.9% | — |
| Return on equity | −33.6% | −125.8% | — | 0.3% | −25.8% |
| Return on tangible equity | −85.4% | −296.7% | — | 0.3% | −30.2% |
| Piotroski F-score | 3 | 3 | — | — | 4 |
| Altman Z'' | −1.0 | −14.2 | — | −19.0 | — |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Aurora Cannabis Inc · ACB
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $4.15 a share, the company is worth $238M.
Source: SEC EDGAR XBRL filings (CIK 0001683541). Data updated October 24, 2026. Filed in CAD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.